2024 Annual Meeting | C110 - Spinocerebellar and Spastic Ataxias: Diagnosis and Management

Date Tuesday 04/16/24

Time 07:00 AM - 09:00 AM MDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Oksana Suchowersky, MD, FAAN

Topic(s) Movement Disorders

Learning Objectives Participants should become familiar with the differential diagnoses, investigation, and management of patients with hereditary spinocerebellar and spastic ataxias. Particular attention will be given to benefits and limitations of genetic testing, different types of genetic testing, update on pathophysiology, and potential for new and genetic therapies.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Quality Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Program Evaluations

Event Timeline
07:00 AM - 07:40 AM MDT	Speaker	The Autosomal Dominant Spinocerebellar Ataxias: Diagnosis and Treatment Oksana Suchowersky, MD, FAAN
07:40 AM - 08:20 AM MDT	Speaker	The Recessive Spinocerebellar Ataxias; Diagnosis and Treatment Massimo Pandolfo, MD, FAAN
08:20 AM - 08:40 AM MDT	Discussion	Case Presentations Oksana Suchowersky, MD, FAAN
08:40 AM - 09:00 AM MDT	Discussion	Case Presentations Massimo Pandolfo, MD, FAAN

Faculty Disclosures
Oksana Suchowersky, MD, FAAN	Dr. Suchowersky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos/Alexion. The institution of Dr. Suchowersky has received research support from Roche. The institution of Dr. Suchowersky has received research support from Wave LifeSciences. The institution of Dr. Suchowersky has received research support from CHDI. Dr. Suchowersky has received publishing royalties from a publication relating to health care. Dr. Suchowersky has received publishing royalties from a publication relating to health care.
Massimo Pandolfo, MD, FAAN	Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Design Therapeutics . Dr. Pandolfo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Bio. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Design Therapeutics. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Pandolfo has stock in Voyager Therapeutics. The institution of Dr. Pandolfo has received research support from Freidreich Ataxaia Research Alliance. Dr. Pandolfo has a non-compensated relationship as a Scientific Advisory Board with Friedreich Ataxia Research Alliance that is relevant to AAN interests or activities. Dr. Pandolfo has a non-compensated relationship as a Member-Meeting Management Committee with AAN that is relevant to AAN interests or activities.

��ɫ��

��ɫ��